首页 › 基金 › Affinity Asset Advisors, LLC › BLTE

Affinity Asset Advisors, LLC 对 BLTE 的持仓历史

BELITE BIO INC · 医疗保健

Affinity Asset Advisors, LLC 在 Q3 2026 的 13F 申报中披露持有 BLTE(BELITE BIO INC)242,088 股,市值约 US$41.1M,约占其申报组合的 1.91%,在其申报持仓中市值排名第 15 位。 Affinity Asset Advisors, LLC 最近 4 个申报季度中有 4 个季度披露了 BLTE 持仓,最早可追溯至 Q4 2025。

最新持仓 (Q3 2026)242.09K 股
申报持仓市值$41.11M
组合权重1.91%
首次申报Q4 2025
最近变动增持
更新于2026-11-14

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

Affinity Asset Advisors, LLC 对 BLTE 的持仓演变

Affinity Asset Advisors, LLC 于 Q4 2025 首次披露 BLTE 持仓:20,000 股(约 US$3.2M)。 该持仓在 Q3 2026 达到峰值 242,088 股,市值约 US$41.1M。 在 4 次申报中,Affinity Asset Advisors, LLC 3 次增持、0 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 242,088 股、市值约 US$41.1M,环比增持 77,088 股。。 持仓曾出现大幅变动:Q1 2026 增持约 225% (随后一个季度股价下跌 3%)、Q2 2026 增持约 154% (随后一个季度股价上涨 10%)、Q3 2026 增持约 47% (随后一个季度股价下跌 3%)。

逐季持仓明细

季度股数金额变化
Q4 2025 20.00K $3.20M 新进
Q1 2026 65.00K $10.36M 增持
Q2 2026 165.00K $25.41M 增持
Q3 2026 242.09K $41.11M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 BLTE 与 13F 数据

BLTE(BELITE BIO INC)属于医疗保健行业。我们追踪的基金中还有 73 只申报持有 BLTE,申报仓位最大的包括:Darwin Global Management, Ltd. (US$456.6M), Paradigm Biocapital Advisors LP (US$189.8M), RTW INVESTMENTS, LP (US$110.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 BLTE 的基金

查看 BLTE 的全部基金持有人 →

常见问题

How long has Affinity Asset Advisors, LLC held BLTE?

Affinity Asset Advisors, LLC has disclosed BLTE holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Affinity Asset Advisors, LLC's current position in BLTE?

As of Q3 2026, Affinity Asset Advisors, LLC holds 242.09K shares of BLTE (BELITE BIO INC), valued at $41.11M, representing 1.91% of its reported portfolio and ranking #15.

Has Affinity Asset Advisors, LLC been buying or selling BLTE?

In the latest 13F filing (Q3 2026), Affinity Asset Advisors, LLC increased its position in BLTE. The position peaked in Q3 2026 at 242.09K shares.

Which other funds hold BLTE?

Other major institutional holders of BLTE include Darwin Global Management, Ltd., Paradigm Biocapital Advisors LP, RTW INVESTMENTS, LP, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.